ISPO

Novel Immunotherapy

Novel human intratumoral immunotherapy

T Tursz, ScD MD

Idiotype-vaccination with idiotype-pulsed dendritic cells

Heribert Bohlen, MD

New advances in the evaluation of the immuno-biology of melanoma

AI Riker MD, US Kammula MD, MC Pannelli PhD, KH Lee MD, E Wang MD, FM Marincola MD

C-MYB directed oligodeoxynucleotides for the treatment of human leukemia: report of a four year, forty patient experience.

AM Gewirtz

Xenotherapy

M Soulilou, MD